Thomas Walter
Impact in
Papers in
- Co-authors
- Jennifer J. KnoxAnne M. HorganEitan AmirCatherine Lombard‐BohasJean‐Yves HumbertJaboury GhazoulValérie HervieuJean‐Yves Scoazec
- Journals
- Journal of Clinical Oncology (20 papers)Neuroendocrinology (14 papers)European Journal of Endocrinology (9 papers)Endoscopy (8 papers)Annals of Oncology (7 papers)
- Partner nations
- FranceGermanySwitzerland
In The Last Decade
Thomas Walter
313 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 188
- Oncology 2.9k
- Neurology 1.6k
- Epidemiology 2.7k
- Nature and Landscape Conservation 506
- Gastroenterology 206
Countries citing papers authored by Thomas Walter
This map shows the geographic impact of Thomas Walter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Walter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Walter more than expected).
Fields of papers citing papers by Thomas Walter
This network shows the impact of papers produced by Thomas Walter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Walter. The network helps show where Thomas Walter may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Walter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 19 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 3 | |
| 8 | 2022 | 1 | |
| 9 | Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumors - An international double-blind, placebo-controlled randomized phase 2. Prodige 31 REMINET. A FFCD study | 2021 | 0 |
| 10 | Patient and Nurse Satisfaction with the New Lanreotide Autogel Pre-Filled Syringe in Neuroendocrine Tumors (NET): A Prospective Study (SONATE) | 2020 | 1 |
| 11 | 2020 | 4 | |
| 12 | 2017 | 8 | |
| 13 | Implication of Neuropilin-2 in the Progression of Small Intestinal Neuroendocrine Tumors: Towards a Promising Therapeutic Target | 2017 | 1 |
| 14 | 2015 | 24 | |
| 15 | A Multicenter, Randomized, Blinded, Phase 3 Study of Pasireotide LAR vs Octreotide LAR in Patients with Metastatic Neuroendocrine Tumors (NET) with Disease-Related Symptoms Inadequately Controlled by Somatostatin Analogs | 2014 | 2 |
| 16 | 2013 | 10 | |
| 17 | 2010 | 31 | |
| 18 | 2009 | 12 | |
| 19 | 1988 | 2 | |
| 20 | 1970 | 4 |
About Thomas Walter
Thomas Walter is a scholar working on Oncology, Neurology, Epidemiology, Internal Medicine and Gastroenterology, having authored 331 papers that have together received 6.5k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (126 papers), Lung Cancer Research Studies (93 papers), Neuroblastoma Research and Treatments (65 papers), Pancreatic and Hepatic Oncology Research (45 papers), Gastrointestinal Tumor Research and Treatment (15 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), Venous Thromboembolism Diagnosis and Management (12 papers) and Ecology and Vegetation Dynamics Studies (12 papers). The work is most often cited by research in Oncology (2.9k citations), Neurology (1.6k citations), Epidemiology (2.7k citations), Nature and Landscape Conservation (506 citations) and Gastroenterology (206 citations). Thomas Walter has collaborated with scholars based in France, Germany and Switzerland. Frequent co-authors include Jennifer J. Knox, Anne M. Horgan, Eitan Amir, Catherine Lombard‐Bohas, Jean‐Yves Humbert, Jaboury Ghazoul, Valérie Hervieu, Jean‐Yves Scoazec, Nina Richner and Béatrice Schüpbach. Their work appears in journals such as Journal of Clinical Oncology, Neuroendocrinology, European Journal of Endocrinology, Endoscopy and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.